Pharmacological activation of p53 triggers viral mimicry response thereby promoting anti-tumor immunity

被引：0
|
作者：
Selivanova, Galina [1 ]
Zhou, Xiaolei [1 ]
Singh, Madhurendra [1 ]
Sanz, Gema [1 ]
Guerlavais, Vincent [2 ]
Carvajal, Luis A. [2 ]
Aivado, Manuel [2 ]
Annis, Allen [2 ]
Zhan, Yue [1 ,2 ]
Oliveira, Mariana [1 ]
Westerberg, Lisa [1 ]
Johnsen, John I. [3 ]
机构：
[1] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Solna, Sweden
[2] Aileron Therapeut Inc, Cambridge, MA 02472 USA
[3] Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S10-1
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [21] Selective anti-tumor activity of wogonin targeting the Warburg effect through stablizing p53
    Zhao, Yikai
    Zhang, Lulu
    Wu, Yifan
    Dai, Qinsheng
    Zhou, Yuxin
    Li, Zhiyu
    Yang, Lin
    Guo, Qinglong
    Lu, Na
    PHARMACOLOGICAL RESEARCH, 2018, 135 : 49 - 59
  • [22] Adrenergic regulation of the anti-tumor immune response in p53-deficient tumors
    Silverman, Deborah A.
    Akhter, Shamima
    Xie, Tongxin
    Islam, Shajedul
    Anfossi, Simone
    Covello, Jennifer D.
    Gleber-Netto, Frederico O.
    Doorduijn, Elien
    Wang, Yunfei
    Ashkin, Emily L.
    Myers, Jeffrey N.
    Calin, George A.
    Hwu, Patrick
    Amit, Moran
    CLINICAL CANCER RESEARCH, 2023, 29 (18)
  • [23] Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer
    Sznarkowska, Alicja
    Olszewski, Robert
    Zawacka-Pankau, Joanna
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2010, 64 : 396 - 407
  • [24] Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirus
    Hashimoto, Masashi
    Kuroda, Shinji
    Kanaya, Nobuhiko
    Kadowaki, Daisuke
    Yoshida, Yusuke
    Sakamoto, Masaki
    Hamada, Yuki
    Sugimoto, Ryoma
    Yagi, Chiaki
    Ohtani, Tomoko
    Kumon, Kento
    Kakiuchi, Yoshihiko
    Yasui, Kazuya
    Kikuchi, Satoru
    Yoshida, Ryuichi
    Tazawa, Hiroshi
    Kagawa, Shunsuke
    Yagi, Takahito
    Urata, Yasuo
    Fujiwara, Toshiyoshi
    BRITISH JOURNAL OF CANCER, 2024, 130 (07) : 1187 - 1195
  • [25] Cabozantinib eradicates de novo castrate-resistant PTEN/p53 deficient murine prostate cancer via activation of neutrophil-mediated anti-tumor innate immunity
    Patnaik, Akash
    Swanson, Kenneth
    Helenius, Katja
    Thomas, Thornley
    Pyzer, Athalia
    Csizmadia, Vilmosne
    Signoretti, Sabina
    Morgan, Todd
    Wang, Yugang
    Elemento, Olivier
    Wang, Lily
    Levantini, Elena
    Clohessy, John
    Asara, John
    Smith, David
    Rosenblatt, Jacalyn
    Avigan, David
    Balk, Steven
    Cantley, Lewis
    CANCER RESEARCH, 2015, 75
  • [26] Novel Anti-Tumor Combination of Virotherapy & Phytotherapy Against Cancer Cells that Enhance P53 Expression
    Al-Shammari, Ahmed M. H.
    Jalill, Raghad D. Abdul
    Kalel, Mustafa A.
    MOLECULAR THERAPY, 2020, 28 (04) : 161 - 162
  • [27] p53 anti-tumor research in Bel-7402 by using human-derived vector
    Zhi-Gang, Xue
    Jian, Li
    Biao, Yin
    Zhang Ya-Kun
    Liu Xiong-Hao
    Pan Qian
    Long Zhi-Gao
    Dai He-Ping
    Xia Kun
    Wu Ling-Qian
    Liang De-Sheng
    Xia Jia-Hui
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (05) : 465 - 470
  • [28] TET2-mediated tumor cGAS triggers endothelial STING activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer
    Hongwei Lv
    Qianni Zong
    Cian Chen
    Guishuai Lv
    Wei Xiang
    Fuxue Xing
    Guoqing Jiang
    Bing Yan
    Xiaoyan Sun
    Yue Ma
    Liang Wang
    Zixin Wu
    Xiuliang Cui
    Hongyang Wang
    Wen Yang
    Nature Communications, 15
  • [29] Unlike p53, p27 failed to exhibit an anti-tumor genetic interaction with Ku80
    Holcomb, Valerie B.
    Vogel, Hannes
    Hasty, Paul
    CELL CYCLE, 2009, 8 (15) : 2463 - 2466
  • [30] Activation of the cytosolic RNA receptor RIG-I in tumor and immune cells triggers efficient anti-tumor immunity and synergizes with checkpoint blockade
    Heidegger, S.
    Alexander, W.
    Kreppel, D.
    Bscheider, M.
    Bek, S.
    Fischer, J.
    Schmickl, M.
    Ruland, J.
    Peschel, C.
    Haas, T.
    Poeck, H.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S22 - S22
12345